Ventricular	B:C0428940
Effective	I:C0428940
Refraction	I:C0428940
Period	I:C0428940
and	O
Ventricular	B:C3537202
Repolarization	I:C3537202
Analysis	B:C0936012
in	O
Experimental	O
Tachycardiomyopathy	B:C0878544
in	O
Swine	B:C0039005
.	O

Swine	B:C0039005
are	O
recognized	O
animal	B:C0012644
models	I:C0012644
of	O
human	B:C0086418
cardiovascular	B:C0007222
diseases	I:C0007222
.	O

However	O
,	O
little	O
is	O
known	O
on	O
the	O
CHF	B:C0018802
-	O
associated	O
changes	O
in	O
the	O
electrophysiological	B:C0449381
ventricular	I:C0449381
parameters	I:C0449381
of	O
humans	B:C0086418
and	O
animals	B:C0003062
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
changes	O
in	O
the	O
durations	O
of	O
ventricular	B:C0428940
effective	I:C0428940
refraction	I:C0428940
period	I:C0428940
(	O
ventricular	B:C0428940
effective	I:C0428940
refraction	I:C0428940
period	I:C0428940
)	O
,	O
QT	B:C0429028
and	O
QTc	O
intervals	O
of	O
pigs	B:C0039005
with	O
chronic	O
tachycardia	B:C0039231
-	O
induced	O
tachycardiomyopathy	B:C0878544
(	O
tachycardia	B:C0878544
-	I:C0878544
induced	I:C0878544
tachycardiomyopathy	I:C0878544
)	O
.	O

The	O
study	O
was	O
comprised	O
of	O
28	O
adult	O
pigs	B:C0039005
(	O
8	O
females	O
and	O
20	O
males	O
)	O
of	O
the	O
Polish	B:C0024660
Large	I:C0024660
White	I:C0024660
breed	I:C0024660
.	O

A	O
one	B:C0030163
-	I:C0030163
chamber	I:C0030163
pacemaker	I:C0030163
was	O
implanted	O
in	O
each	O
of	O
the	O
28	O
pigs	B:C0039005
.	O

Electrocardiographic	B:C0180580
,	O
echocardiographic	B:C0013516
and	O
electrophysiological	O
studies	O
were	O
carried	O
out	O
prior	O
to	O
the	O
pacemaker	B:C0189842
implantation	I:C0189842
and	O
at	O
subsequent	O
4	O
-	O
week	O
intervals	O
.	O

All	O
electrocardiographic	B:C0180580
,	O
echocardiographic	B:C0013516
and	O
short	O
electrophysiological	O
study	O
measurements	O
in	O
all	O
swine	B:C0039005
were	O
done	O
under	O
general	B:C0002915
anesthesia	I:C0002915
(	O
propofol	B:C0033487
)	O
after	O
premedication	B:C0033045
with	O
midazolam	B:C0026056
,	O
medetomidine	B:C0125656
,	O
and	O
ketamine	B:C0022614
.	O

No	O
significant	O
changes	O
in	O
the	O
duration	O
of	O
QT	B:C0429028
interval	I:C0429028
and	O
corrected	O
QT	O
interval	O
(	O
QTc	O
)	O
were	O
observed	O
during	O
consecutive	O
weeks	O
of	O
the	O
experiment	B:C0681814
.	O

The	O
duration	O
of	O
the	O
QTc	O
interval	O
of	O
female	O
pigs	B:C0039005
was	O
shown	O
to	O
be	O
significantly	O
longer	O
than	O
that	O
of	O
the	O
males	O
throughout	O
the	O
whole	O
study	B:C2603343
period	O
.	O

Beginning	O
from	O
the	O
12th	O
week	O
of	O
rapid	O
ventricular	B:C0199648
pacing	I:C0199648
,	O
a	O
significant	O
increase	O
in	O
duration	O
of	O
ventricular	B:C0428940
effective	I:C0428940
refraction	I:C0428940
period	I:C0428940
was	O
observed	O
in	O
both	O
male	O
and	O
female	O
pigs	B:C0039005
.	O

Males	O
and	O
females	O
did	O
not	O
differ	O
significantly	O
in	O
terms	O
of	O
ventricular	B:C0428940
effective	I:C0428940
refraction	I:C0428940
period	I:C0428940
duration	O
determined	O
throughout	O
the	O
whole	O
study	B:C2603343
period	O
.	O

Ventricular	B:C0199648
pacing	I:C0199648
,	O
stimulation	B:C1292856
with	O
2	O
and	O
3	O
premature	O
impulses	O
at	O
progressively	O
shorter	O
coupling	O
intervals	O
and	O
an	O
imposed	O
rhythm	B:C0871269
of	O
130	O
bpm	O
or	O
150	O
bpm	O
induced	O
transient	O
ventricular	B:C0042514
tachycardia	I:C0042514
in	O
one	O
female	O
pig	B:C0039005
and	O
four	O
male	O
pigs	B:C0039005
.	O

One	O
episode	O
of	O
permanent	O
ventricular	B:C0042514
tachycardia	I:C0042514
was	O
observed	O
.	O

The	O
number	O
of	O
induced	O
arrhythmias	B:C0085612
increased	O
proportionally	O
to	O
the	O
severity	O
of	O
heart	B:C0018801
failure	I:C0018801
and	O
duration	O
of	O
the	O
experiment	B:C0681814
.	O

However	O
,	O
relatively	O
aggressive	O
protocols	B:C0442711
of	O
stimulation	B:C1292856
were	O
required	O
in	O
order	O
to	O
induce	O
arrhythmia	B:C0085612
in	O
the	O
studied	O
pigs	B:C0039005
.	O

